关注
Sherouk Fouda
标题
引用次数
引用次数
年份
Metabolic complications of hepatitis C virus infection
R Chaudhari, S Fouda, A Sainu, JM Pappachan
World journal of gastroenterology 27 (13), 1267, 2021
542021
Matrine protects against MCD-induced development of NASH via upregulating HSP72 and downregulating mTOR in a manner distinctive from metformin
A Mahzari, S Li, X Zhou, D Li, S Fouda, M Alhomrani, W Alzahrani, ...
Frontiers in Pharmacology 10, 405, 2019
272019
Involvement of the autophagy-ER stress axis in high fat/carbohydrate diet-induced nonalcoholic fatty liver disease
X Zhou, S Fouda, D Li, K Zhang, JM Ye
Nutrients 12 (9), 2626, 2020
192020
Characterization of the therapeutic profile of albiflorin for the metabolic syndrome
X Zhou, S Fouda, XY Zeng, D Li, K Zhang, J Xu, JM Ye
Frontiers in pharmacology 10, 1151, 2019
172019
Management of metabolic-associated fatty liver disease: The diabetology perspective
MS Jeeyavudeen, SKA Khan, S Fouda, JM Pappachan
World Journal of Gastroenterology 29 (1), 126, 2023
122023
Pregnancy and metabolic-associated fatty liver disease: a clinical update
S Fouda, MM Vennikandam, JM Pappachan, CJ Fernandez
Journal of Clinical and Translational Hepatology 10 (5), 947, 2022
82022
Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress
S Fouda, A Khan, SMH Chan, A Mahzari, X Zhou, CX Qin, R Vlahos, ...
Clinical science 135 (17), 2103-2119, 2021
82021
Cigarette smoking blocks the benefit from reduced weight gain for insulin action by shifting lipids deposition to muscle
A Khan, S Fouda, A Mahzari, SMH Chan, X Zhou, C Ratnam, R Vlahos, ...
Clinical Science 134 (13), 1659-1673, 2020
72020
Pathobiology of Metabolic-Associated Fatty Liver Disease
S Fouda, MS Jeeyavudeen, JM Pappachan, V Jayanthi
Endocrinology and Metabolism Clinics 52 (3), 405-416, 2023
52023
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
MS Jeeyavudeen, R Chaudhari, JM Pappachan, S Fouda
World Journal of Gastroenterology 29 (3), 487, 2023
42023
Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
ZD Luo, YF Wang, YX Zhao, LC Yu, T Li, YJ Fan, SJ Zeng, YL Zhang, ...
World Journal of Gastroenterology 29 (1), 1, 2023
22023
Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue
S Li, X Zhou, E Jo, A Mahzari, S Fouda, D Li, K Zhang, JM Ye
Bioscience reports 38 (6), BSR20181873, 2018
22018
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge.
S Fouda, JM Pappachan
Endocrinology and Metabolism Clinics of North America 52 (3), xv-xvi, 2023
12023
WJH
KJ Dabos
World 16 (2), 112-114, 2024
2024
Metabolic-associated fatty liver disease and sarcopenia: A double whammy
A Viswanath, S Fouda, CJ Fernandez, JM Pappachan
World Journal of Hepatology 16 (2), 152, 2024
2024
How does cigarette smoking aggravate hepatic steatosis to non-alcoholic steatohepatitis?
SMA FOUDA
RMIT University, 2021
2021
Cigarette smoking causes glucose intolerance with involvement of the wasting and insulin resistance in muscle
A Khan, S Fouda, A Mahzari, S Chan, R Vlahos, J Ye
AUSTRALASIAN JOURNAL ON AGEING 39, 50-50, 2020
2020
Legacy effects of high fat preconditioning against metabolic syndrome with enhanced metabolic capacity in muscle and adipose tissue
J Ye, X Zhou, S Li, E Jo, A Mahzari, S Fouda
Obesity Research & Clinical Practice 13 (3), 299, 2019
2019
Preconditioning lessens high fat induced metabolic syndrome along with markers of increased metabolic capacity in muscle and adipose tissue.
LSP Li SongPei, ZX Zhou Xiu, JEJ Jo EunJung, A Mahzari, S Fouda, ...
2018
Repurposing matrine for the treatment of non-alcoholic fatty liver disease
AMA Mahzari
RMIT University, 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–20